BioSpace News Archive

Infertility Is a Common Struggle for Both Sexes. The Innovative French Health Brand Gynov Is Addressing This Concern with Myo-Inositol.

MannKind Corporation (Nasdaq: MNKD) will release its 2021 fourth quarter and full year financial results, and its management will host a conference call to discuss the financial results and corporate updates at 5:00 p.m. (Eastern Time) on Thursday, February 24, 2022.

HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi , M.D. as Chief Medical Officer and Chief Development Officer at HanAll Pharmaceutical International.

SummerBio LLC, a diagnostic company that provides affordable, high-quality, high-volume COVID-19 PCR testing, announced that it is expanding its COVID-19 PCR testing capabilities and opening a new lab facility in Menlo Park.

The industry analysis report is considered a valuable source of information about the global Incontinence Devices industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market. The report also highlights about changes in the market dynamics due to outbreak of the COVID-19 pandemic.

The report also highlights about changes in the market dynamics due to outbreak of the COVID-19 pandemic.

Positive high-level results from the pivotal DESTINY-Breast04 Phase III trial showed ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival (PFS) and overall survival (OS) in patients with HER2-low unresectable and/or metastatic breast cancer regardless of hormone receptor (HR) status versus physician’s choice of chemotherapy.

POP02 is one of several cohort studies within the Collaboration to Assess Risk and Identify LoNG-term outcomes for Children with COVID, known as CARING for Children with COVID.

Rapidly growing geriatric population and rising prevalence of respiratory diseases are among the major factors driving the global market revenue growth.